CSL Behring - Unipessoal, Lda - Piso 3ºFrente

5/5 based on 1 reviews

About CSL Behring - Unipessoal, Lda

The Commonwealth Serum Laboratories was established in Australia in 1916 to service the health needs of a nation isolated by war. Over the ensuing years CSL provided Australians with rapid access to 20th century medical advances including insulin and penicillin, and vaccines against influenza, polio and other infectious diseases. CSL Limited was incorporated in 1991 and listed on the Australian Securities Exchange (ASX) in 1994.

Since then, CSL has acquired a number of companies. They include: Aventis Behring, which is now known as global biotechnology leader CSL Behring; U.S. plasma collector Nabi, which helped to form the world's premier plasma collection company in CSL Plasma; the Novartis influenza vaccine business, now integrated and known as Seqirus, one of the largest influenza vaccine providers in the world; Calimmune, a leader in gene-modification and cell delivery technology; and Vitaeris, a biopharmaceutical company focused on the development of clazakizumab as a potential treatment option for organ transplant recipients experiencing rejection. Their combined and rich histories make CSL the innovative global leader it is today.

Contact CSL Behring - Unipessoal, Lda

Address :

Edifício Mar Vermelho, Av. D. João II, Nº50, Piso 3ºFrente, 1990-095 Lisboa, Portugal

Phone : 📞 +78
Postal code : 1990
Website : http://www.cslbehring.com/
Categories :
City : Lisboa

Edifício Mar Vermelho, Av. D. João II, Nº50, Piso 3ºFrente, 1990-095 Lisboa, Portugal

Write some of your reviews for the company CSL Behring - Unipessoal, Lda

Your reviews will be very helpful to other customers in finding and evaluating information

Rating *
Your review *

(Minimum 30 characters)

Your name *